Siemens Healthineers Financials
SMMNY Stock | USD 27.92 0.11 0.40% |
Siemens |
Please note, the imprecision that can be found in Siemens Healthineers' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Siemens Healthineers AG. Check Siemens Healthineers' Beneish M Score to see the likelihood of Siemens Healthineers' management manipulating its earnings.
Siemens Healthineers Stock Summary
Siemens Healthineers competes with Merck KGaA, CSL, Essilor International, Hoya Corp, and Chugai Pharmaceutical. Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers worldwide. Siemens Healthineers AG operates as a subsidiary of Siemens Aktiengesellschaft. SIEMENS HEALTHINEERS is traded on OTC Exchange in the United States.Instrument | USA Pink Sheet View All |
Exchange | PINK Exchange |
ISIN | US82622J1043 |
Business Address | Henkestrasse 127, Erlangen, |
Sector | Healthcare |
Industry | Medical Devices |
Benchmark | Dow Jones Industrial |
Website | www.siemens-healthineers.com |
Phone | 49 9131 84 3385 |
Currency | USD - US Dollar |
Siemens Healthineers Key Financial Ratios
Siemens Healthineers' financial ratios allow both analysts and investors to convert raw data from Siemens Healthineers' financial statements into concise, actionable information that can be used to evaluate the performance of Siemens Healthineers over time and compare it to other companies across industries.Return On Equity | 0.11 | |||
Return On Asset | 0.0383 | |||
Target Price | 30.96 | |||
Beta | 0.61 | |||
Last Dividend Paid | 0.95 |
Siemens Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Siemens Healthineers's current stock value. Our valuation model uses many indicators to compare Siemens Healthineers value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Siemens Healthineers competition to find correlations between indicators driving Siemens Healthineers's intrinsic value. More Info.Siemens Healthineers AG is currently regarded as top stock in return on equity category among its peers. It also is currently regarded as top stock in return on asset category among its peers reporting about 0.34 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Siemens Healthineers AG is roughly 2.95 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Siemens Healthineers by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Siemens Healthineers' Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Siemens Healthineers Systematic Risk
Siemens Healthineers' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Siemens Healthineers volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was five with a total number of output elements of fifty-six. The Beta measures systematic risk based on how returns on Siemens Healthineers correlated with the market. If Beta is less than 0 Siemens Healthineers generally moves in the opposite direction as compared to the market. If Siemens Healthineers Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Siemens Healthineers is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Siemens Healthineers is generally in the same direction as the market. If Beta > 1 Siemens Healthineers moves generally in the same direction as, but more than the movement of the benchmark.
Siemens Healthineers March 24, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Siemens Healthineers help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Siemens Healthineers AG. We use our internally-developed statistical techniques to arrive at the intrinsic value of Siemens Healthineers AG based on widely used predictive technical indicators. In general, we focus on analyzing Siemens Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Siemens Healthineers's daily price indicators and compare them against related drivers.
Downside Deviation | 1.52 | |||
Information Ratio | 0.0554 | |||
Maximum Drawdown | 7.95 | |||
Value At Risk | (2.48) | |||
Potential Upside | 2.78 |
Additional Tools for Siemens Pink Sheet Analysis
When running Siemens Healthineers' price analysis, check to measure Siemens Healthineers' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Siemens Healthineers is operating at the current time. Most of Siemens Healthineers' value examination focuses on studying past and present price action to predict the probability of Siemens Healthineers' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Siemens Healthineers' price. Additionally, you may evaluate how the addition of Siemens Healthineers to your portfolios can decrease your overall portfolio volatility.